Ascletis Pharma (1672.HK) Q3 2025 Earnings

15AugConfirmed
Q1 2024
Q3 2024
Q1 2025
Q3 2025
-0.18
-0.15
-0.13
-0.1

Details

Expected EPS
-0.14190063602000003
Actual EPS
-0.0997670625556
Surprise EPS
0.04
Surprise Percent
+29.69%

Description

Ascletis Pharma (1672.HK) has reported earnings of -0.0997670625556 per share for Q3 2025.

0 Comments

Share your thoughts